Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The characteristics of included patientsVariablesTotal(n = 6075)ASCVD risk (low to intermediate) (n = 4800)ASCVD risk (high)(n = 1275)Statistics P Age, years, Mean (S.E)54.31 (0.18)52.09 (0.16)66.91 (0.30)t = 42.891< 0.001Gender, n (%)χ² = 180.425< 0.001Female3114 (51.49)2694 (54.85)420 (32.40)Male2961 (48.51)2106 (45.15)855 (67.60)Race, n (%)χ² = 19.482< 0.001Mexican American944 (6.88)765 (7.06)179 (5.84)Non-Hispanic Black1279 (9.69)873 (8.56)406 (16.10)Non-Hispanic White2555 (72.33)2062 (72.77)493 (69.84)Other Hispanic658 (4.82)549 (5.01)109 (3.72)Other Race639 (6.28)551 (6.60)88 (4.50)Education level, n (%)χ² = 6.4820.014Above or college graduate3359 (64.97)2740 (65.87)619 (59.84)Below college graduate2716 (35.03)2060 (34.13)656 (40.16)PIR, n (%)χ² = 0.1530.842< 1933 (8.95)747 (8.87)186 (9.43)≥ 14649 (84.78)3658 (84.88)991 (84.20)Unknown493 (6.27)395 (6.25)98 (6.38)Marital status, n (%)χ² = 2.7790.102Married3689 (66.04)2935 (66.46)754 (63.61)No married2386 (33.96)1865 (33.54)521 (36.39)BMI, n (%)χ² = 4.7540.014Underweight/normal1494 (25.38)1208 (26.02)286 (21.79)Overweight2200 (37.19)1725 (37.32)475 (36.46)Obesity2381 (37.43)1867 (36.67)514 (41.75)Smoking, n (%)χ² = 19.730< 0.001No5007 (83.78)4038 (84.80)969 (78.01)Yes1068 (16.22)762 (15.20)306 (21.99)Drinking, n (%)χ² = 5.5940.002< once/week1676 (28.84)1356 (29.27)320 (26.43)≥ once/week1950 (39.62)1559 (40.45)391 (34.89)Never drinking1527 (18.76)1214 (18.10)313 (22.48)Unknown922 (12.78)671 (12.18)251 (16.21)Physical activity, n (%)χ² = 7.9120.001< 450 MET·min/week694 (11.05)536 (10.86)158 (12.14)≥ 450 MET·min/week3890 (67.23)3152 (68.41)738 (60.50)Unknown1491 (21.73)1112 (20.73)379 (27.37)Sedentary time, n (%)χ² = 1.7260.186< 7.5 h3933 (60.04)3091 (59.48)842 (63.24)≥ 7.5 h2118 (39.61)1691 (40.17)427 (36.40)Unknown24 (0.35)18 (0.35)6 (0.36)Diabetes, n (%)χ² = 199.537< 0.001No2531 (44.99)2291 (49.58)240 (18.93)Yes3544 (55.01)2509 (50.42)1035 (81.07)Diabetes drugs, n (%)χ² = 83.411< 0.001No5335 (90.83)4358 (92.86)977 (79.32)Yes740 (9.17)442 (7.14)298 (20.68)Hypertension drugs, n (%)χ² = 112.170< 0.001No4046 (69.40)3496 (73.63)550 (45.40)Yes2029 (30.60)1304 (26.37)725 (54.60)Lipid-lowering therapy, n (%)χ² = 61.388< 0.001No4772 (78.13)3959 (80.81)813 (62.88)Yes1303 (21.87)841 (19.19)462 (37.12)Nonsteroidal drugs, n (%)χ² = 0.6800.414No5710 (94.61)4519 (94.74)1191 (93.91)Yes365 (5.39)281 (5.26)84 (6.09)Anti-infective drugs, n (%)χ² = 2.2220.143No5813 (95.11)4583 (94.89)1230 (96.33)Yes262 (4.89)217 (5.11)45 (3.67)TC, mg/dL, Mean (S.E)203.28 (0.77)203.61 (0.81)201.37 (1.68)t = -1.2980.200HDL-C, mg/dL, Mean (S.E)54.63 (0.38)55.20 (0.41)51.37 (0.59)t = -6.004< 0.001HbAlc, %, Mean (S.E)5.73 (0.02)5.66 (0.02)6.13 (0.04)t = 10.525< 0.001Serum vitamin D, n (%)χ² = 0.9960.323< 50 nmol/L1703 (19.81)1325 (19.57)378 (21.16)≥ 50 nmol/L4372 (80.19)3475 (80.43)897 (78.84)WBC, 1000 cells/uL, Mean (S.E)6.95 (0.05)6.94 (0.05)7.05 (0.09)t = 1.3590.181Decayed teeth, n (%)χ² = 4.6270.013No21 (0.31)14 (0.27)7 (0.52)Unknown4268 (76.62)3437 (77.38)831 (72.33)Yes1786 (23.06)1349 (22.34)437 (27.15)Oral hygiene, n (%)χ² = 6.0790.004Yes2684 (34.74)2028 (33.72)656 (40.52)Unknown3381 (65.15)2762 (66.15)619 (59.48)No10 (0.11)10 (0.13)0 (0.00)Dental floss, n (%)χ² = 6.2310.007No1801 (25.11)1319 (24.03)482 (31.26)Unknown44 (0.41)32 (0.41)12 (0.42)Yes4230 (74.48)3449 (75.56)781 (68.32)Energy, kcal, Mean (S.E)2147.37 (18.35)2162.82 (20.74)2059.65 (33.63)t = -2.6050.012Carbohydrate, gm, Mean (S.E)252.88 (2.28)254.62 (2.58)243.01 (4.07)t = -2.4050.020Vitamin C, mg, Mean (S.E)84.16 (2.08)84.11 (2.21)84.39 (3.55)t = 0.0760.940Zinc-RDA, n (%)χ² = 15.939< 0.001No2861 (43.15)2169 (42.02)692 (49.61)Yes3214 (56.85)2631 (57.98)583 (50.39)Periodontitis, n (%)χ² = 104.060< 0.001No2424 (48.77)2129 (52.04)295 (30.21)Yes3651 (51.23)2671 (47.96)980 (69.79)Zinc, mg, Mean (S.E)11.48 (0.12)11.51 (0.13)11.35 (0.29)t = -0.5410.591Mean (S.E), mean (standard error); PIR, poverty-to-income ratio; BMI, body mass index; MET, metabolic equivalent of task; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; HbAlc, glycated hemoglobin; WBC, white blood cell count; RDA, recommended dietary allowances

Source: Selection and characteristics of patients. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The regulatory effect of zinc on the association between periodontitis and atherosclerotic cardiovascular disease: a cross-sectional study based on the National Health and Nutrition Examination Survey

Source: Article title.

Periodontitis patients aged 40 to 79 years old from NHANES database in 2009 to 2014 were included in this study.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The regulatory effect of zinc on the association between periodontitis and atherosclerotic cardiovascular disease: a cross-sectional study based on the National Health and Nutrition Examination Survey

Cross-sectional study · BMC Oral Health · 2024

Original publication title

The regulatory effect of zinc on the association between periodontitis and atherosclerotic cardiovascular disease: a cross-sectional study based on the National Health and Nutrition Examination Survey

Xiuxiu Yang; Maoyu Luo; Yao Jiang

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study found the regulatory effect of adequate zinc intake on the association between periodontitis and ASCVD, providing guidance for periodontitis patients to decrease the risk of ASCVD.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Zinc has been proven to be effective against periodontitis, and also reported to reduce the risk of cardiovascular diseases (CVD). This study aims to explore the regulatory effect of zinc intake on the association between periodontitis and atherosclerotic cardiovascular disease (ASCVD).

Source: Background

Abstract: What methods does the paper describe?

This was a cross-sectional study based on the National Health and Nutrition Examination Survey (NHANES). Logistic regression model was used to explore the association between zinc-RDA or periodontitis and 10-year ASCVD risk ≥ 20%, and results were shown as odds ratio (OR) and 95% confidence interval (95% CI). The regulatory effect of zinc intake on the association between periodontitis and 10-year ASCVD risk ≥ 20% was also assessed using logistic regression model. Subgroup analysis was performed based on age, gender, obesity, education level, lipid-lowering therapy, and dental floss.

Source: Methods

Abstract: Results

6,075 patients were finally included for analysis. Zinc intake reaching the recommended level (OR = 0.82, 95%CI: 0.69 to 0.98) and periodontitis (OR = 2.47, 95%CI: 2.04-3.00) were found to be associated with 0.82-fold and 2.47-fold odds of 10-year ASCVD risk ≥ 20%, respectively. In addition, we found that the odds of 10-year ASCVD risk ≥ 20% was lower in patients with zinc intake reaching the recommended level than those without [OR (95%CI): 2.25 (1.81 to 2.80) vs. 2.72 (2.05 to 3.62)]. The similar regulatory effect was found in patients with age ≥ 60 years and < 60 years, in male and female, with or without obesity, in different education levels, with or without lipid lowering therapy, and with or without use of dental floss (all P < 0.05).

Source: Results

Abstract: Conclusions

This study found the regulatory effect of adequate zinc intake on the association between periodontitis and ASCVD, providing guidance for periodontitis patients to decrease the risk of ASCVD.

Source: Conclusions
Authors’ abstract

Background

Zinc has been proven to be effective against periodontitis, and also reported to reduce the risk of cardiovascular diseases (CVD). This study aims to explore the regulatory effect of zinc intake on the association between periodontitis and atherosclerotic cardiovascular disease (ASCVD).

Methods

This was a cross-sectional study based on the National Health and Nutrition Examination Survey (NHANES). Logistic regression model was used to explore the association between zinc-RDA or periodontitis and 10-year ASCVD risk ≥ 20%, and results were shown as odds ratio (OR) and 95% confidence interval (95% CI). The regulatory effect of zinc intake on the association between periodontitis and 10-year ASCVD risk ≥ 20% was also assessed using logistic regression model. Subgroup analysis was performed based on age, gender, obesity, education level, lipid-lowering therapy, and dental floss.

Results

6,075 patients were finally included for analysis. Zinc intake reaching the recommended level (OR = 0.82, 95%CI: 0.69 to 0.98) and periodontitis (OR = 2.47, 95%CI: 2.04-3.00) were found to be associated with 0.82-fold and 2.47-fold odds of 10-year ASCVD risk ≥ 20%, respectively. In addition, we found that the odds of 10-year ASCVD risk ≥ 20% was lower in patients with zinc intake reaching the recommended level than those without [OR (95%CI): 2.25 (1.81 to 2.80) vs. 2.72 (2.05 to 3.62)]. The similar regulatory effect was found in patients with age ≥ 60 years and < 60 years, in male and female, with or without obesity, in different education levels, with or without lipid lowering therapy, and with or without use of dental floss (all P < 0.05).

Conclusions

This study found the regulatory effect of adequate zinc intake on the association between periodontitis and ASCVD, providing guidance for periodontitis patients to decrease the risk of ASCVD.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12903-024-04473-6.

Publication and source details

Original title: The regulatory effect of zinc on the association between periodontitis and atherosclerotic cardiovascular disease: a cross-sectional study based on the National Health and Nutrition Examination Survey

Xiuxiu Yang; Maoyu Luo; Yao Jiang

BMC Oral Health · 2024

© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T10:56:28.133941+00:00

DOI: 10.1186/s12903-024-04473-6 · PMC11184828